EF
BMRN icon

Empowered Funds’s BioMarin Pharmaceuticals BMRN Stock Holding History

Empowered Funds’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.88M Buy
33,203
+3,776
+13% +$220K 0.01% 1142
2025
Q4 		$1.75M Sell
29,427
-122,669
-81% -$6.68M 0.03% 520
2025
Q3 		$8.24M Buy
152,096
+142,595
+1,501% +$8.15M 0.08% 301
2025
Q2 		$522K Sell
9,501
-2,522
-21% -$149K 0.01% 1300
2025
Q1 		$850K Buy
12,023
+8,112
+207% +$546K 0.01% 1054
2024
Q4 		$257K Buy
+3,911
New +$262K ﹤0.01% 1429
2024
Q3 		– Sell
-2,677
Closed -$220K – 1400
2024
Q2 		$220K Buy
2,677
+294
+12% +$24.5K ﹤0.01% 1275
2024
Q1 		$208K Buy
+2,383
New +$213K ﹤0.01% 1296

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return